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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYmiR-302/367 is themost abundantmiRNA cluster in human embryonic stem cells (hESCs) and can promote somatic cell reprogramming.
However, its role in hESCs remains poorly understood. Here, we studied functional roles of the endogenousmiR-302/367 cluster in hESCs
by employing specific TALE-based transcriptional repressors. We revealed that miR-302/367 cluster dually regulates hESC cell cycle and
apoptosis in dose-dependent manner. Gene profiling and functional studies identified key targets of the miR-302/367 cluster in regu-
lating hESC self-renewal and apoptosis.We demonstrate that in addition to its role in cell cycle regulation,miR-302/367 cluster conquers
apoptosis by downregulating BNIP3L/Nix (a BH3-only proapoptotic factor) and upregulating BCL-xL expression. Furthermore, we show
that butyrate, a natural compound, upregulates miR-302/367 cluster expression and alleviates hESCs from apoptosis induced by knock-
down of miR-302/367 cluster. In summary, our findings provide new insights inmolecular mechanisms of howmiR-302/367 cluster reg-
ulates hESCs.INTRODUCTION
Human embryonic stem cells (hESCs) are valuable re-
sources for regenerative medicine because of their unlim-
ited and rapid self-renewal capacity and differentiation
potential to generate all cell types in the body (Xu et al.,
2009). However, culturing hESCs has been more techni-
cally challenging than culturing mouse ESCs because
they have problematic properties such as slow growth
and sensitivity to apoptosis upon cellular detachment
and dissociation (Watanabe et al., 2007). hESCs usually
undergo massive cell death particularly after complete
dissociation, and cloning efficiency of dissociated hESCs
is generally%1% (Amit et al., 2000; Pyle et al., 2006; Thom-
son et al., 1998). Although much recent efforts have
been devoted to finding small molecules that can improve
hESC survival after passage (Bajpai et al., 2008; Emre
et al., 2010; Watanabe et al., 2007), the molecular mecha-
nisms that govern hESC survival are not completely
understood.
MicroRNAs (miRNAs) are 18–24 nucleotide-long non-
coding RNAs that bind and cleave mRNAs or inhibit their
translation (Ambros, 2004; Bartel, 2004). Recent studies
demonstrate that miRNAs play important roles in modu-
lating hESC self-renewal and differentiation and somatic
cell reprogramming (Anokye-Danso et al., 2011; Lin et al.,
2011; Miyoshi et al., 2011; Wang et al., 2008, 2014; Xu
et al., 2009; Zhang et al., 2013). Among these miRNAs,
miR-302/367 cluster is highly expressed in hESCs andStemhuman embryonic carcinoma cells, and overexpression of
this miRNA cluster can maintain stemness of hESCs and
promote somatic cell reprograming (Anokye-Danso et al.,
2011; Suh et al., 2004). However, how the endogenous
miR-302/367cluster regulates hESC self-renewal or growth
remains largely unknown.
In the present study, we studied functional roles of
the endogenous miR-302/367 cluster in hESCs using a
new knockdown approach mediated by transcription acti-
vator-like effector (TALE)-based transcriptional repressor
(TALE-KRAB). We demonstrated that miR-302/367 cluster
dually regulates cell cycle and apoptosis pathways in hESCs
in a gene dose-dependent manner. Consistent with this
finding, we identified several key cell cycle regulators that
are negatively regulated by miR-302/367 cluster. By per-
forming a human apoptosis PCR array and 30UTR luciferase
reporter assay, we identified BNIP3L/Nix, a BH3-only proap-
optotic gene, as a direct target gene of miR-302/367 cluster.
We also revealed that miR-302/367 cluster modulates BCL-
xL expression in hESCs and overexpression of BCL-xL res-
cues hESCs from apoptosis and their growth defect caused
by knockdown of miR-302/367 cluster. Furthermore, we
showed that butyrate, a natural compound and histone de-
acetylase inhibitor, can upregulate expression of miR-302/
367 cluster in hESCs and thus alleviates their apoptosis
induced by knockdown of miR-302/367 cluster. In sum-
mary, our data uncover previously unrecognized new func-
tions of miR-302/367 cluster in dual regulation of both cell
cycle and apoptosis pathways in hESCs.Cell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authors 645
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Figure 1. Role of the Endogenous miR-302/367 Cluster in Regulation of hESC Growth
(A) qPCR analysis of mature miR-302/367 members in hESCs stably expressing control-KRAB and TALE1-KRAB. hESCs were infected with
control-KRAB or TALE1-KRAB. Transcripts of miR-302/367 members were analyzed by qPCR using specific primers. Data are represented as
mean ± SD of technical replicates (n = 3).
(B) Scheme of a GFP fluorescence-based growth competition assay. GFP+ hESCs (control-KRAB or TALE1-KRAB) and GFP hESCs (WT) were
mixed at nearly 1:1 ratio and cultured together for two passages. The ratio of GFP+ andGFP cells was determined before and after passaging.
(C) Percentage of GFP+ cell populations in hESCs stably expressing control-KRAB or TALE1-KRAB. (Left) A representation of flow cytometric
analysis of GFP+ cells before and after passage. (Right) Percentage of GFP+ cells in hESCs stably expressing control-KRAB or TALE1-KRAB
before and after passage. Data are a representative of two independent experiments.
(legend continued on next page)
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RESULTS
Knockdown of the Endogenous miR-302/367 Cluster
Attenuates hESC Self-Renewal
We previously constructed TALE-based transcriptional re-
pressors that specifically bind to the promoter region of
human miR-302/367 cluster and could efficiently inhibit
the elevated expression of primary miR-302/367 during
reprogramming (Zhang et al., 2013). To understand func-
tional roles of the endogenous miR-302/367 cluster in
hESCs, we first determined whether TALE1-KRAB, an
miR-302/367 cluster-specific TALE-based transcriptional
repressor constructed previously (Zhang et al., 2013), could
efficiently knock down the expression of five mature miR-
302/367 members. We generated lentiviral particles ex-
pressing TALE1-KRAB or control-KRAB (with a GFPmarker)
and transduced them into hESCs, respectively. We sorted
GFP+-transduced hESCs and measured the expression of
five mature miR-302/367 members by qPCR. As shown
in Figure 1A, TALE1-KRAB evenly inhibited expressions
of five mature miR-302/367 members by 80% when com-
pared with the control-KRAB group.
It has been shown that overexpression of miR-302/367
cluster regulates G1-S transition inmouse ESCs and reduces
the proliferation rate of cancer cells (Cai et al., 2013; Fareh
et al., 2012; Lin et al., 2010; Wang et al., 2008). Thus, we
first assessed effects of the endogenous miR-302/367 clus-
ter on hESC growth. To do so, we performed a competitive
growth assay by mixing hESCs stably expressing control-
KRAB or TALE1-KRAB with a similar number of WT hESCs
(Figure 1B). The percentage of GFP-positive cells before
passaging was 54.4% and 44.5% of total cells for control-
KRAB- and TAL1-KRAB-expressing hESCs, respectively.
After two passages, the percentage of hESCs expressing
control-KRAB remained almost the same (59.8%), but the
percentage of hESCs expressing TALE-KRAB was decreased
to 12% after passaging (Figure 1C). These data indicated
that the endogenous miR-302/367 cluster is essential for
hESCs growth during culture. To further verify this obser-
vation, we measured cell number of hESCs expressing con-
trol-KRAB and TALE1-KRAB. We found that proliferation
rate of hESCs expressing control-KRAB and WT hESCs is
nearly the same, but hESCs expressing TALE1-KRAB grow
much slower than the control groups (Figure 1D). Further-
more, wemeasured the sizes and numbers of hESC colonies
after seeding an equal number of hESCs expressing TALE1-(D) The effects of miR-302/367 cluster on the growth of hESCs. W
were seeded alone in 12-well plate (7,000 cells per well). The cells w
mean ± SD of three independent experiments (**p < 0.01). See also
(E) Pluripotency analysis of hESCs stably expressing control-KRAB or T
was assessed by analysis of SSEA4 expression with anti-SSEA4 antibo
StemKRAB or control-KRAB (control group). Our data showed
that the TALE1-KRAB group had fewer total numbers of col-
onies, fewer large and medium colonies, and more small
colonies when compared with control-KRAB (Figure S1).
In addition, we analyzed expression of hESC marker
SSEA4 on the surfaces of hECSs expressing control-KRAB
and TALE1-KRAB by flow cytometry. Our data showed
that expression of SSEA4 on hESCs in the two groups is
comparable, indicating that knockdown of the endoge-
nous miR-302/367 cluster does not significantly affect
hESC pluripotency under normal culturing conditions
(Figure 1E). Therefore, we concluded that knockdown of
the endogenous miR-302/367 cluster impairs hESC self-
renewal capacity.
Knockdown of the Endogenous miR-302/367 Cluster
Causes Cell Cycle Arrest and Apoptosis in hESCs
Self-renewing hESCs usually have a longer cell cycle S
phase and lower apoptotic rate.
Our data showed that knockdown of the endogenous
miR-302/367 cluster impairs hESC self-renewal capacity
(Figure 1); we thus hypothesized that miR-302/367 cluster
regulates cell cycle and/or apoptosis in hESCs. To test our
hypothesis, we first assessed the effects of the endogenous
miR-302/367 cluster on the hESC cell cycle. We dissociated
stable hESC lines, incubated them with Vybrant DyeCycle
Violet, and followed by flow cytometric analysis. Our data
show that indeed hESCs expressing TALE1-KRAB accumu-
lated in cell cycle G0/G1 phase, with a concomitant
decrease in the fraction of cells in S or G2/M phrase (Fig-
ure 2A). Next, we measured proliferation of hESCs in the
two groups by performing EdU incorporation assay. As
shown in Figure 2B, EdU incorporation rate was signifi-
cantly reduced in hESCs expressing TALE1-KRAB when
compared with control-KRAB group, indicating that
knockdown of the endogenous miR-306/367 cluster de-
creases hESC proliferation. Furthermore, we decided to
determine whether knockdown of the endogenous miR-
302/367 cluster causes apoptosis in hESCs during cell
culture. To address this question, we dissociated hESCs ex-
pressing control-KRAB or TALE1-KRAB, stained them with
Annexin V-APC, and performed analysis by flow cytome-
try. As shown in Figure 2C, hESCs expressing TALE1-
KRAB exhibited a significantly higher apoptotic rate
when compared with hESCs expressing control-KRAB.
These data indicate that the endogenous miR-302/367T hESCs or stable expressing control-KRAB or TALE1-KRAB-hESCs
ere then counted at indicated time points. Data are represented as
Figure S1.
ALE1-KRAB by flow cytometry. Pluripotency of GFP+ cell population
dy. Data are a representative of two independent experiments.
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Figure 2. Role of miR-302/367 Cluster in Regulation of Cell Cycle and Apoptosis of hESCs
(A) Cell cycle analysis of hESCs-expressing control-KRAB or TALE1-KRAB by flow cytometry. Cells were dissected and stained by Vybrant
Dyecycle according to manufacturer’s instructions. A representative graph of analyzing cell cycle processed with the FlowJo program was
shown in the left, and analysis of cell cycle phase distribution was shown in the right. Data are represented as mean ± SD of three in-
dependent experiments (*p < 0.05, **p < 0.01).
(B) Analysis of proliferating hESCs by EdU staining. hESCs expressing control-KRAB or TALE1-KRAB were cultured in 24-well plate overnight
and then followed by the addition of EdU solution for 1 hr. Cells were dissected for EdU detection using the Click-iT detection kit. Data are
represented as mean ± SD of three independent experiments (**p < 0.01).
(C) Flow cytometric analysis of apoptotic hESCs. Control-KRAB- or TALE1-KRAB-expressing hESCs were stained with Annexin V-APC and
then analyzed by flow cytometry (left). The percentage of Annexin V+ cells was determined (right). Data are represented as mean ± SD of
three independent experiments (**p < 0.01).cluster is required to prevent hESCs from apoptosis during
cell culture.
Endogenous miR-302/367 Cluster Dually Regulates
Cell Cycle and Apoptosis in hESCs in a Dose-
Dependent Manner
Collectively, our data show that the endogenous miR-
302/367 cluster is essential for both hESC self-renewal
and apoptosis (Figures 1 and 2). Now, a key question
arises: how can this cluster regulate both self-renewal and648 Stem Cell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authoapoptosis pathways? Based on miRNAs-specific modula-
tion mechanism, one miRNA can regulate multiple target
genes, and one gene can be targeted by multiple miRNAs.
A previous study also showed that gene dose of each
miRNA affects target selection and regulation (Shu et al.,
2012). Therefore, we hypothesized that miR-302/367
cluster can dually regulate cell cycle and apoptosis path-
ways in hESCs in gene dose-dependent manner. To prove
this hypothesis, we expanded hESCs expressing TALE1-
KRAB and sorted four populations of hESCs based on GFPrs
fluorescence: population I (P-I, GFPnegative), population II
(P-II, GFPlow), population III (P-III, GFPmedium), and popula-
tion IV (P-IV, GFPhigh). The three populations (P-II, P-III,
P-IV) of hESCs express three different levels of GFP fluores-
cence: low, medium, and high. We extracted total RNAs
from these four hESC populations and analyzed the tran-
scripts of primary miR-302/367 by qPCR. Our data showed
that the expression levels of pri-miR-302/367 in cell popu-
lations expressing low, medium, and high level of GFP was
reduced to 70%, 40%, and 20% of the level in the control
group (P-I), respectively (Figure 3B). These data indicated
that the GFP fluorescence level is reversely correlated
with the expression of the endogenous miR-302/367 clus-
ter (Figures 3A and 3B). Next we stained these cells with
both Vybrant DyeCycle Violet and Annexin V-APC and
then analyzed cell cycle and apoptosis in each of the sorted
populations by flow cytometry (Figures 3C–3E). Compared
with the group with 70% of expression level (P-II), the
group with 40% of expression level of miR-302/367 (P-III)
accumulated in G0/G1-phase and had a decreased fre-
quency of S-phase cells (Figure 3D). Interestingly, when
the expression level of the miR-302/367 cluster was
reduced to 20% (P-IV), we found a sharp decrease of hESCs
in cell cycle G0/G1 and S phases and a dramatic increase of
hESCs in G2/M phase (Figure 3D).
Furthermore, we measured apoptosis rate in each of the
sorted populations by Annexin V-APC staining. Our data
showed that the percentage of apoptotic cells was compara-
ble in the groups II and III, which express approximately
70% and 40% of the expression level of the endogenous
miR-302/367 cluster. Notably, we observed a sharp increase
of apoptotic cells in the group IV that only express 20%
of the expression level of the endogenous miR-302/367
(Figure 3E). These data clearly indicated that the endoge-
nous miR-302/367 cluster dually regulates cell cycle and
apoptosis in hESCs in a dose-dependent manner (Figures
3D and 3E).
miR-302/367 Cluster Regulates Molecular Targets
Essential for hESC Cell Cycle and Apoptosis Pathways
Because transforming growth factor-b1 (TGF-b1) is in-
volved in apoptotic pathways in several types of cells (Lee
and Bae, 2002; Schuster and Krieglstein, 2002), we thus
asked whether miR-302/367 cluster regulates apoptosis
via TGF-b1 signaling. To address this question, we treated
two groups of hESCs (control-KRAB versus TALE1-KRAB)
with or without TGF-b1 or SB431542 (a chemical inhibitor
of TGF-b1 receptor). Our data showed that TGF-b1 or
SB431542 had little effect on apoptosis in hESCs expressing
TALE1-KRAB or control-KRAB (Figure S2). To dissect the
molecular mechanisms by which miR-302/367 cluster
dually regulates cell cycle and apoptosis in hESCs, we
examined the expression of 21 cell cycle regulators byStemqPCR and found that knockdown of the endogenous
miR-302/367 cluster by TALE1-KRAB inhibits the expres-
sion of BMI-1, CDK2, CCND1, CCND2, CDK6 (Figure 4A;
Table S1). It has been shown that these molecules play
important roles in regulation of G0/G1- to S-phase transi-
tion (Abdelalim, 2013). Thus, it is likely that the endo-
genous miR-302/367 cluster controls hESC cell cycle pro-
gression through the regulation of these key cell cycle
regulators.
In contrast to cell cycle regulation, roles of miR-302/367
cluster in regulation of hESC apoptosis have not been
explored. To identify potential targets of the endogenous
miR-302/367 cluster in regulation of hESC apoptosis
pathway, we compared expression profiles of human
apoptosis-associated genes between the two groups of
hESCs (control-KRAB versus TALE1-KRAB) by performing
Human Apoptosis PCR array. We found that knockdown
of miR-302/367 cluster results in upregulation of six genes
and downregulation of five genes, respectively (Figure 4B;
Table S2). Among these targets, we confirmed by qPCR
that expression of BNIP3L/Nix was induced more than 4-
fold and that BCL-xL was downregulated 2-fold in hESCs
expressing TALE1-KRAB (Figure 4C). Our western blot
analysis showed that protein expression of BNIP3L/Nix
and BCL-xL was also affected in hESCs by TALE1-KRAB
(Figure 4D).
miRNAs usually inhibit translation of theirmRNA targets
by binding with 30UTR of their targets (Wang et al., 2008).
We thus hypothesized that the endogenous miR-302/367
cluster inhibits apoptosis by suppressing the expression
of proapoptotic genes. Among the six upregulated genes
in hESCs expressing TALE1-KRAB, BNIP3L/Nix encodes a
BH3-only proapoptotic factor and has been reported to
induce apoptosis when its expression was induced or over-
expressed in cells (Chen et al., 2010). Hence, we analyzed
30UTR of BNIP3L/Nix by the miRNA target search software
(http://www.microrna.org) and found that two sites in
the 30UTR of BNIP3L/Nix are potential recognition sites
for miR-302/367 mature members (miR-302b, miR-302c,
miR-302a, miR-302d) (Figure 4E). To determine whether
BNIP3L/Nix is a true target of miR-302/367 cluster. We
cloned the DNA fragment covering BNIP3L/Nix 30UTR
into pGL3-control luciferase vector and thenmuted its first
(BS1) or second (BS2) or both potential recognition sites of
miR-302/367 mature members (Figures 4E and S3). Next,
we carried out a 30UTR luciferase reporter assay to validate
this bioinformatic prediction by transfecting each re-
porter together with an expression vector for miR-302/
367 cluster. Our data revealed that the luciferase reporter
containing WT BNIP3L/Nix 30UTR was inhibited 50% by
miR-302/367 cluster, whereas the mutations in either sites
partially relieved the inhibition, and the double mutations
fully rescued the inhibition, indicating that both sitesCell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authors 649
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Figure 3. miR-302/367 Cluster Dually Regulates Cell Cycle and Apoptosis of hESC in a Dose-Dependent Manner
(A) Diagram of the gating strategy for hESC populations with different expression of TALE1-KRAB. hESCs were gated based GFP expression
level (negative, low, medium, and high) and the following corresponding four populations were gated: P-I, GFPnegative; P-II, GFPlow; P-III,
GFPmedium; P-IV, GFPhigh. Low, Med, and High were hESCs with low GFP fluorescence, medium GFP fluorescence, and high GFP fluorescence,
respectively.
(B) qPCR analysis of pri-miR-302/367 in four populations of hESCs expressing different level of TALE1-KRAB indicated by GFP fluorescence.
Data are represented as mean ± SD of technical replicates (n = 3).
(legend continued on next page)
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Figure 4. Target Genes of miR-302/367
Cluster Associated with Cell Cycle and
Apoptosis in hESCs
(A) qPCR analysis of potential targets of
miR-302/367 cluster regulating cell cycle in
hESCs. Data are represented as mean ± SD of
technical replicates (n = 3). See also Fig-
ure S2 and Table S1.
(B) Screening of apoptosis-related target
genes of the miR-302/367 cluster. Patterns
of gene expression were compared between
the hESCs expressing control-KRAB or
TALE1-KRAB using Apoptosis PCR Array. See
also Table S2.
(C) qPCR analysis of BNIP3L and BCL-xL
gene expression in control-KRAB- and
TALE1-KRAB-expressing hESCs. Data are
represented as mean ± SD of technical rep-
licates (n = 3).
(D) Western blot analysis of BINP3L/Nix and
BCL-xL in control-KRAB- and TALE1-KRAB-
expressing hESCs. BINP3L/Nix and BCL-xL
were detected by western blot analysis with
each specific antibody. Relative expression
of the BINP3L/Nix and BCL-xL was quanti-
fied by Image J (NIH) and normalized by
G6PD.
(E) Schematic representation of the reporter
construct containing the luciferase-coding
sequence fused to the BNIP3L/Nix 30UTR.
Two predicted targeting sites for miR-302/
367 cluster were designated as BS1 and BS2.
See also Figure S3.
(F) BNIP3L/Nix 30UTR luciferase reporter
assay. 293T cells were transfected with the
reporter plasmid pGL3-BNIP3L/Nix carrying
mutations BS1 or BS2 or both, together with
pMIGR1 (vector control) or pMIGR1_miR-302/367 and then cultured for 72 hr before luciferase activity assay. pCMV-LacZ was included in
each transfection as an internal control to normalize luciferase activity. Data are represented as mean ± SD of three independent ex-
periments (**p < 0.01).contributed to the negative regulation by miR-302/367
cluster (Figure 4F). Interestingly, both BS1 and BS2 sites
were only targeted by miR-302/367 cluster in human
but not in mouse and rat, suggesting a unique regulatory
role of the endogenous miR-302/367 cluster in hESC
apoptosis.(C) A representative flow cytometry analysis of cell cycle and apopt
fluorescence (P-I, P-II, P-III, P-IV).
(D) Cell cycle phase distribution of hESCs expressing different level of
gated as shown in (A) and analyzed as shown in (C), and their cell cyc
represented as mean ± SD of three independent experiments (**p <
(E) Percentage of apoptotic cells in hESCs with a decreased expression
represented by the sub-G0/G1 fraction of events in the four population
independent experiments (**p < 0.01).
StemmiR-302/367 Cluster Regulates hESC Self-Renewal
Mainly through the Inhibition of Apoptosis Pathway
So far, our data demonstrated that miR-302/367 cluster is
required for hESC growth (Figure 1) and can dually regulate
cell cycle and apoptosis in hESCs (Figures 3 and 4). To
dissect molecular pathways by which the endogenousosis in the four populations of cells with different degree of GFP
TALE1-KRAB. The four cell populations (P-I, P-II, P-III, P-IV) were
le distribution was calculated and shown as a percentage. Data are
0.01).
level of miR-302/367 cluster. The apoptotic population of cells was
s (P-I, P-II, P-III, P-IV). Data are represented as mean ± SD of three
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Figure 5. miR-302/367 Cluster Predomi-
nantly Regulates Apoptosis in hESCs
(A) Percentage of apoptotic cells in hESCs
expressing control-KRAB, TALE1-KRAB,
BCL-xL, or both TALE1-KRAB and BCL-xL.
Cells were stained with Annexin V-APC and
analyzed by flow cytometry. Data are rep-
resented as mean ± SD of three independent
experiments (*p < 0.05, **p < 0.01). See
also Figure S4.
(B) Effect of apoptosis on cell growth of
hESCs with knockdown of miR-302/367
cluster. hESCs expressing either TALE1-
KRAB (left) or both TALE1-KRAB and BCL-xL
(right) were cultured, passaged for several
times, and then analyzed for GFP+ cells.
The percentage of GFP+ cells was calculated
for hESCs expressing TALE1-KRAB or both
TALE1-KRAB and BCL-xL before and after
passaging (lower). Data are represented as
mean ± SD of three independent experi-
ments (**p < 0.01; N.S, no significance).miR-302/367 cluster regulates hESC self-renewal, we over-
expressed antiapoptotic gene BCL-xL (with a mCherry
marker) in the TALE1-KRAB-expressing hESCs and exam-
ined the effects of BCL-xL on apoptosis in these cells.
Significantly, our data showed that overexpression of
BCL-xL not only rescued hESC from apoptosis caused by
knockdown of the endogenous miR-302/367 cluster but
also partially blocked the spontaneous apoptosis in WT
hESCs (Figure 5A). Next, we assessed effects of BCL-xL on
proliferation of hESCs expressing TALE1-KRAB using the
competitive growth assay as described in Figure 1B. Our
data showed that hESCs expressing TALE1-KRAB have
growth disadvantage compared with WT hESCs, which is
similar with the result shown in Figures 1C and 1D, but
forced expression of BCL-xL enables TALE1-KRAB-express-
ing hESCs to regain their normal growth capacity. Because
it was reported that BCL-xL is also involved in cell cycle
regulation (Cheng et al., 2003; Janumyan et al., 2003), we
analyzed cell cycle profile of the three groups of hESCs652 Stem Cell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authothat express control-KRAB or TALE1-KRAB or both TALE1-
KRAB and BCL-xL. As shown in Figure S4, BCL-xL only in-
hibits apoptosis but does not affect cell cycle progression in
TALE1-KRAB hESCs. Collectively, our data undoubtedly
demonstrated that the endogenous miR-302/367 cluster
regulates hESC self-renewal predominantly through the in-
hibition of apoptosis in hESCs (Figure 5B).
Butyrate Suppresses BNIP3L/Nix Expression through
the Upregulation of miR-302/367 Cluster Expression
Our data established that knockdown of the endogenous
miR-302/367 cluster impairs hESC self-renewal by trig-
gering apoptosis. We thus predicted that increasing miR-
302/367 cluster expression would restore normal growth
of hESCs by alleviating them from apoptosis. Recently,
we found that butyrate, a natural compound and histone
deacetylase inhibitor, can enhance the expression of pri-
mary miR-302/367 during reprogramming process (Zhang
andWu, 2013). Thus, we hypothesized that butyratemightrs
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Figure 6. Butyrate Alleviates Apoptosis
from hESC Induced by Knockdown of
miR-302/367 Cluster
(A) qPCR analysis of pri-miR-302/367 tran-
scripts in hESCs expressing control-KRAB-
and TALE1-KRAB treated with or without
butyrate (0.25, 0.5 mM) for 72 hr. Data are
represented as mean ± SD of technical rep-
licates (n = 3). See also Figure S5.
(B) qPCR analysis of BNIP3L/Nix transcripts
in hESCs expressing control-KRAB- and
TALE1-KRAB treated with or without buty-
rate (0.25, 0.5 mM) for 72 hr. Data are
represented as mean ± SD of technical rep-
licates (n = 3).
(C) Effect of butyrate on apoptosis induced
by knockdown of miR-302/367 cluster.
hESCs expressing control-KRAB or TALE1-
KRAB-hESCs were treated with or without
butyrate (0.25, 0.5 mM) for 72 hr and then
assessed by flow cytometric analysis after
staining with Annexin V-APC. Data are rep-
resented as mean ± SD of three independent
experiments (**p < 0.01).
(D) Effects of butyrate on growth of hESCs
with knockdown of miR-302/367 cluster.
hESCs stably expressing TALE1-KRAB were culture in medium with or without butyrate and percentage of GFP+ cells were analyzed by flow
cytometry. Data are represented as mean ± SD of three independent experiments (**p < 0.01).rescue, partially if not completely, hESC apoptosis induced
by knockdown of endogenous miR-302/367 cluster. To test
this hypothesis, we first tested the optimal concentrations
of butyrate for modulating expression of miR-302/367
cluster because butyrate concentrations commonly used
in cell culture (>1.0 mM) were toxic to hESCs. We found
that lower concentrations of butyrate (0.25 to 0.5 mM)
enhanced the expression of five mature miR-302/367
members (Figure S5). Interestingly, a low concentration of
butyrate (0.5mM)was previously shown to promote hESCs
self-renewal in the absence of basic fibroblast growth factor
(bFGF) (Ware et al., 2009). As expected, forced expression of
TALE1-KRAB decreased the expression of miR-302/367
cluster by 2.5-fold, and butyrate induced expression of
pri-miR-302/367 cluster in the control group of hESCs ex-
pressing control-KRAB by 2-fold (Figure 6A). Interestingly,
butyrate treatment elevated expression of pri-miR-302/
367 in hESCs expressing TALE1-KRAB to a level similar
with that in the control group before butyrate treatment.
Next, we measured by qPCR expression of BNIP3L/Nix, a
target gene of miR-302/367 cluster in these cell groups.
In agreement with our result (Figure 4), upregulation of
miR-302/367 cluster by butyrate treatment downregulated
BNIP3L/Nix expression to a level, which was comparable
with the control groups (Figure 6B). Together, our data indi-
cated that butyrate is able to suppress BNIP3L/Nix expres-Stemsion by upregulating the expression of endogenous miR-
302/367 cluster.
Butyrate Inhibits Apoptosis and Restores Normal
Growth in hESCs with Knockdown of miR-302/367
Cluster
Because our data suggested that BNIP3L/Nix is a primary
mediator for apoptosis induced by knockdown of miR-
302/367 cluster in hESCs, thus we asked whether restoring
expressionof the endogenousmiR-302/367 cluster by buty-
rate would inhibit apoptosis in hESCs expressing TALE1-
KRAB. To address this question, we measured apoptosis by
Annexin V-APC staining in six groups of hESCs expressing
either control-KRAB or TALE1-KRAB, which were treated
with or without butyrate (Figure 6C). Significantly, our
data showed that butyrate indeed suppressed apoptosis
in hESCs expressing TALE1-KRAB, indicating that in-
hibiting BNIP3L/Nix expression is sufficient to suppress
apoptosis pathway mediated by knockdown of miR-302/
367 cluster. Since knockdown of miR-302/367 cluster
induced apoptosis in hESCs and impaired their self-renewal
(Figures 1 and 5), we thus applied a competitive growth
assay as described in Figure 1B to compare relative growth
rate of hESCs expressing TALE1-KRAB grown in medium
withorwithout butyrate. Aswe expected, hESCs expressing
TALE1-KRAB had growth disadvantage compared with WTCell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authors 653
cells when cultured in medium without butyrate (Fig-
ure 6D). In contrast, hESCs expressing TALE1-KRAB
restored their normal growth rate when grown in medium
with butyrate (Figure 6D). Collectively, these data demon-
strate that butyrate inhibits apoptosis induced by a reduced
expression of miR-302/367 cluster and therefore restores
normal growth of these hESCs.DISCUSSION
Cell proliferation, differentiation, and death are funda-
mental processes in multicellular organisms (Alenzi,
2004) and are controlled by positive and negative regula-
tors. miRNAs, as negative regulators, play critical roles in
self-renewal and differentiation of hESCs (Xu et al.,
2009). Here, using our TALE-based repressor approach to
knock down the endogenous miR-302/367 cluster in
hESCs, we reported that miR-302/367 cluster dually regu-
lates cell cycle and apoptosis of hESCs, and such regulatory
action is dependent on its expression level. Furthermore,
we identified BNIP3L/Nix as a key direct target of miR-
302/367 cluster and determined its predominant regula-
tion on hESC apoptosis pathway.
The functions of miR-302/367 cluster have been investi-
gated in various types of cells, including mouse ESCs,
different cancer cells, and induced pluripotent stem cells
(Cai et al., 2013; Fareh et al., 2012; Lin et al., 2010; Wang
et al., 2008; Zhang et al., 2013). Wang et al. reported that
miR-302 regulates cell cycle G1/S phase transition in hESCs
(Lipchina et al., 2011). In cancer cells, forced expression
of miR-302/367 cluster inhibited cell proliferation and
tumor formation by blocking cell cycle G1/S transition
(Cai et al., 2013; Fareh et al., 2012). Lin et al. (2010) recently
showed that overexpression of miR302s (miR302a,
miR302b, miR302c, miR302d) attenuates normal cell cycle
rate without causing apoptosis in normal cells but causes
massive apoptosis in multiple cancer cell lines. They also
found that treatment of miR302s inhibits teratoma cell
growth of Tera-2 pluripotent human embryonal carcinoma
cells. In contrast, our data showed that knockdown of the
endogenous miR-302/367 cluster induced G0/G1 phase
arrest in hESCs, which is consistent with the previous
findings inmouse and human ESCs (Wang et al., 2008; Lip-
china et al., 2011). Thus, regulatory roles of the endoge-
nous miR-302/367 cluster are different in cancer cells and
mouse ESCs (mESCs) or hESCs. It was known that miR-
302/367 was highly expressed in both hESCs and mESCs,
but it is only slightly or not expressed in cancer cells. There-
fore, the discrepancy from these studies may be partially
due to different expression level of miR-302/367 cluster
in different types of cells and the two different study ap-
proaches employed in these studies. Lin et al. (2010) over-654 Stem Cell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authoexpressed four members of miR302 (miR302a, miR302b,
miR302c, miR302d) but not miR367 in a single vector in
their study. In contrast, we applied a TALE-based repressor
approach to knock down the whole miR-302/367 cluster in
hESCs.
It has been reported that some genes maintain the bal-
ance between the rate of cell proliferation and apoptosis
by regulating both cell cycle and apoptosis pathways
(Alenzi, 2004). Although a recent study reported that
both miR-17-92 and let-7a-7f clusters potentially select
their targets in a dose-dependent and nonlinear fashion
(Shu et al., 2012), it has not been reported previously that
miRNAs can regulate both cell cycle and apoptosis path-
ways in dose-dependent manner. Our current findings
clearly indicate thatmiR-302/367 dually regulates cell cycle
and apoptosis in hESCs, and its action on both processes is
dependent on its endogenous expression level.
Interestingly, Lin et al. (2010) showed that overexpres-
sion of miR302s (miR302a, miR302b, miR302c, miR302d)
induces massive apoptosis in tumor/cancer cell lines.
Scheel et al. (2009) reported that miR-302/367 cluster
expression is reduced in testicular germ cell tumor and tu-
mor suppressor p63 expression is elevated significantly.
Based on these studies, it has been postulated that miR-
302/367 cluster modulates apoptosis in both embryonic
stem cells and cancer cells by suppressing p63 (Kuo et al.,
2012). In the current study, we showed that knockdown
of the endogenous miR-302/367 cluster upregulates
BNIP3L/Nix expression in hESCs and verified BNIP3L/Nix
as a direct target of this cluster. Recently, Pernaute et al.
(2014) showed that three miRNA families (miR-20, miR-
92, and miR-302) control apoptosis in mouse primed
pluripotent stem cells through regulation of Bim. However,
our apoptosis PCR array screening show that BIM is not a
target of the endogenous miR-302/367 cluster in hESCs
(data not shown). Thus, it is possible that miRNAs regulate
apoptosis in mouse and human ESCs through distinctive
molecular mechanisms.
We also revealed that p63 expression is not significantly
affected in hESCs by knockdown of the endogenous miR-
302/367 cluster (Figure S6). Thus, p63 is unlikely a target
of miR-302/367 cluster in hESCs. BNIP3L/Nix belongs to
the Bcl-2 family and is a BH3-only proapoptotic factor.
Overexpression of BNIP3L/Nix is sufficient to induce
apoptosis and necrosis-like cell death (Chen et al., 2010).
Thus, BNIP3L/Nix should be a primary functional target
of the endogenous miR-302/367 cluster in hESCs.
Butyrate is a histone deacetylase inhibitor and can pro-
mote ESC self-renewal across species, accumulate hESCs
in S and G2/M phase, and delay the differentiation
of hESCs (Ware et al., 2009). However, the molecular
mechanisms underlying these actions of butyrate in
hESCs remain elusive. We previously found that butyraters
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Figure 7. A Model for Action of miR-302/367 Cluster in
Regulation of Cell Cycle and Apoptosis in hESCs
miR-302/367 cluster is inducible by sodium butyrate in hESCs, and
it is required to sustain expression of key cell cycle regulators such
as BMI-1, CCND1, CCND2, and CDK6. At the same time, a minimum
level of miR-302/367 cluster is needed to inhibit spontaneous
apoptosis in hESCs by modulates expression of BCL-xL and BH3-only
proapoptotic factor BNIP3L/Nix.promotes cellular reprogramming by inducing the expres-
sion of miR-302/367 cluster (Zhang and Wu, 2013; Zhang
et al., 2013). Here, we showed that butyrate could signifi-
cantly induce expression of miR-302/367 cluster and
downregulate its target gene BNIP3L/Nix in hESCs. Impor-
tantly, butyrate treatment rescues hESCs from apoptosis
induced by knockdown of the endogenous miR-302/367
cluster. Thus, our data suggest that miR-302/367 cluster is
a primary mediator for butyrate’s action in promoting
hESC self-renewal and cell cycle progression (Figure 7).
In summary, our current findings highlight how miR-
302/367 cluster functions as a critical positive regulatorStemthat fine tunes hESC self-renewal capacity by modulating
cell cycle and apoptosis. Based on our findings, we pro-
posed an action model for miR-302/367 cluster in hESCs
(Figure 7). In this model, miR-302/367 cluster governs
cell cycle and apoptosis in hESCs through regulation of
distinct target genes, and it sequentially regulates cell cycle
and apoptosis regulators in dose-dependent manner. Our
findings provide substantial new insight into themolecular
mechanisms for how miR-302/367 controls hESC self-
renewal and apoptosis.EXPERIMENTAL PROCEDURES
Cell Culture
293T cells were cultured in DMEM containing 10% fetal bovine
serum (FBS), and hESCs (H1 line) were cultured on mouse embry-
onic fibroblast (MEF) feeder cells in conventional human ESC cul-
ture medium (DMEM/F12, 20% knockout serum replacement, 1%
Glutamax, 1% non-essential amino acids, 1% penicillin/strepto-
mycin, 0.1-mM b-mercaptoethanol, and 20-ng/ml bFGF) or on
BD gel in mTeSR1 medium (Stem Cell Technologies). All cell cul-
ture products were purchased from Invitrogen except where
mentioned.Construction of Luciferase Reporter and Luciferase
Assay
To construct the luciferase reporter for BNIP3L/Nix, a DNA frag-
ment containing the BNIP3L/Nix 30UTR was amplified by PCR
with specific primers (Table S3) and cloned into pGL3-Control vec-
tor (Promega), and the resultant plasmid was designed as pGL3-
BNIP3L/Nix. To generate the mutant variants, point mutations
in the two miR-302/367 binding sites were introduced by PCR.
293T were cultured in 24-well plate overnight and then co-trans-
fected with 50 ng of the luciferase reporter, 925 ng of pMig or
pMig-miR-302/367, and 25 ng of CMV-LacZ by using Fugene HD
(Roche). After 72 hr of transfection, cells were lysed in 250 ml of
the passive lysis buffer (Promega) and assayed with a luciferase
assay kit (Promega), as directed by themanufacturer. The luciferase
activities were expressed as relative luciferase/LacZ activities,
normalized to those of control transfections in each experiments.Lentivirus Production and Generation of Stable hESC
Lines
For preparation of the lentiviruses, 293T cells were transfected
with amixture of DNA containing 2.5 mg of lentiviral vectors (con-
trol-KRAB or TALE1-KRAB) and 2.5 mg of the packaging mixture
(Genecopoeia) by Fugene HD. Media containing lentiviruses
was collected 24 hr after transfection and filtered through a
0.45-mm pore size filter. To generate stable hESC lines expressing
control-KRAB or TLAE1-KRAB, hESCs were seeded in a 12-well
plate at 5 3 104 cells per well 1 day before transduction and
incubated with lentiviral particles (control-KRAB or TALE1-
KRAB) containing supernatant supplemented with 5-mg/ml poly-
brene (Sigma), followed by centrifugation (1,000 g for 45 min).
At 4 days after infection, infected cells were split using AccutaseCell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The Authors 655
(Millipore) and plated on MEF feeders for expansion. Medium was
changed every other day until 80% confluence. A pool of stable
GFP+ hESCs was sorted by fluorescence-activated cell sorting
(FACS) and seeded into 12-well plate precoated by BD Matrigel
(BD Biosciences).
Western Blot Analysis
Cells were lysed directly with RIPA lysis buffer, supplemented with
protease inhibitor cocktail (Sigma). Cell lysates were separated by
electrophoresis on 12% SDS-PAGE and transferred to a nitrocellu-
lose membrane (Pierce). The blot was blocked with TBST buffer
(20-mM Tris-HCl [pH 7.6], 136-mM NaCl, and 0.05% Tween-20)
containing 5%non-fatmilk and then incubatedwith primary anti-
body solution at 4C overnight. After washing with TBST buffer,
the membrane was incubated with horseradish peroxidase
(HRP)-conjugated secondary antibody for 1 hr at room tempera-
ture. Signals were detected with the ImmobilonWestern Chemilu-
minescent HRP substrate (Pierce). A list of primary antibodies is
included in Table S4.
Flow Cytometry Analysis of Cell Cycle and Apoptosis
For analysis of cell cycle, hESCs were dissociated by Accutase,
pelleted, and resuspended in Hank’s balanced salt solution
(HBSS) at a cell concentration of 13 106 cells/ml. The cell suspen-
sions were incubated with 5-mM Vybrant DyeCycle Violet at 37C
for 30 min and then subjected to flow cytometric analysis.
For EdU incorporation assay, hESCs stably expressing control-
KRAB or TALE1-KRAB were sorted based on GFP fluorescence by
FACS and cultured overnight in 12-well plate precoated BD matri-
gel and then incubated with 10-mM EdU (Invitrogen) in hES cul-
ture medium at 37C for 1 hr. After incubation, cells were dissoci-
ated and labeled with AlexaFluor 647 using the Click-iT EdU Flow
Cytometry Assay kit according to the manufacturer’s instructions
(Invitrogen). EdU+ cells were analyzed by flow cytometry. For anal-
ysis of apoptotic hESCs, hESCs stably expressing control-KRAB or
TALE1-KRAB were sorted by FACS and cultured in hESC medium
for 2 days and dissociated. Cells were stained with Annexin V-
APC antibody according to themanufacturer’s instruction (BDBio-
sciences). Annexin V+GFP+ cells were gated as apoptotic cells. The
apoptotic percentage was determined by flow cytometric analysis.
Gene Expression Analysis by qPCR and PCR Array
Total RNA samples were extracted using the Quick-RNAMicroPrep
Kit (Zymo Research). For qPCR analysis of individual mature miR-
302/367 miRNAs, 200-ng RNA were reverse transcribed using the
NCode VILO miRNA cDNA Synthesis Kit (Invitrogen). For qPCR
analysis of target genes associated with cell cycle arrest and
apoptosis, 500-ng RNA were reverse transcribed using Superscript
III cDNA Synthesis Kit (Invitrogen). GADPH expression was used
as internal control to normalize relative expression of each gene.
For screening apoptotic gene candidates, human apoptosis PCR
array was performed according to the manufacturer’s instructions
(QIAGEN). The list of primers is included in Table S3.
Statistical Analysis
Results are presented as themean ± SD. Data were analyzed by Stu-
dent’s t test; p values% 0.05 were considered significant.656 Stem Cell Reports j Vol. 4 j 645–657 j April 14, 2015 j ª2015 The AuthoSUPPLEMENTAL INFORMATION
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